Skip to content

Clinical trials

Completed Phase 3 Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Phase 3 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20032
20051
20061
20071
20082
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology2
Jonsson Comprehensive Cancer Center2
Memorial Sloan Kettering Cancer Center2
NCIC Clinical Trials Group2
Cancer Research Campaign Clinical Trials Centre1
Case Comprehensive Cancer Center1
European Organisation for Research and Treatment of Cancer - EORTC1
German High-Grade Non-Hodgkin's Lymphoma Study Group1
INSYS Therapeutics Inc1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy16
Lymphoma, Large B-Cell, Diffuse15
Lymphoma, Large-Cell, Anaplastic15
Burkitt Lymphoma14
Lymphoma, Follicular14
Lymphoma, Mantle-Cell14
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma14
Hodgkin Disease13
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, B-Cell, Marginal Zone13

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.